Bruker Corporation  

(Public, NASDAQ:BRKR)   Watch this stock  
Find more results for BRKR
31.79
+0.56 (1.79%)
Feb 23 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 31.17 - 31.96
52 week 21.83 - 36.53
Open 31.51
Vol / Avg. 439,329.00/586,447.00
Mkt cap 5.03B
P/E 34.03
Div/yield 0.04/0.50
EPS 0.93
Shares 155.56M
Beta 1.05
Inst. own 66%
May 22, 2018
Bruker Corp Annual Shareholders Meeting (Estimated) - 9:30AM EDT - Add to calendar
May 1, 2018
Q1 2018 Bruker Corp Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Feb 14, 2018
Bruker Corp at Leerink Partners Global Healthcare Conference - Webcast
Feb 8, 2018
Q4 2017 Bruker Corp Earnings Call - Webcast
Feb 8, 2018
Q4 2017 Bruker Corp Earnings Release
Jan 8, 2018
Bruker Corp at JPMorgan Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '17) 2017
Net profit margin 12.42% 8.45%
Operating margin 17.66% 12.16%
EBITD margin - 17.27%
Return on average assets 13.52% 7.94%
Return on average equity 35.86% 20.78%
Employees 6,000 -
CDP Score - -

Address

40 MANNING RD
BILLERICA, MA 01821
United States - Map
+1-978-6633660 (Phone)
+1-978-6635585 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive detection products. The Bruker Nano segment designs, manufactures and distributes spectroscopy and microscopy instruments. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices. It also focuses on nanomechanical testing instruments.

Officers and directors

Frank H. Laukien Ph.D. Chairman of the Board, President, Chief Executive Officer
Age: 57
Bio & Compensation  - Reuters
Anthony L. Mattacchione Chief Financial Officer, Senior Vice President
Age: 54
Bio & Compensation  - Reuters
Juergen Srega President of Bruker CALID Group and Bruker Daltonics Division
Age: 62
Bio & Compensation  - Reuters
Mark Robert Munch Ph.D. Executive Vice President - President of Bruker Nano Group and Bruker Nano Surfaces Division
Age: 55
Bio & Compensation  - Reuters
William A. Linton Lead Independent Director
Age: 69
Bio & Compensation  - Reuters
Joerg C. Laukien Director
Age: 63
Bio & Compensation  - Reuters
Cynthia M. Friend Ph.D. Independent Director
Age: 62
Bio & Compensation  - Reuters
Marc A. Kastner Ph.D. Independent Director
Age: 71
Bio & Compensation  - Reuters
Richard D. Kniss Independent Director
Age: 76
Bio & Compensation  - Reuters